Pharmafile Logo
Pharmafocus logo
Advanced Search

Law to target economic damage from animal rights protests

November 22, 2004

News

Official claims FDA ‘defenceless’ against another Vioxx

November 22, 2004

News

Strict new conflict of interest rules for MHRA proposed

November 19, 2004

Growing concerns about the independence and transparency of the UK medicines regulator have been met by a set of strict …

News

NHS screening to catch bowel cancer early

November 18, 2004

News

Raptiva launched in first European markets

November 18, 2004

Serono's new psoriasis treatment Raptiva has been launched in its first European markets, including the UK.The drug is licensed to …

News

Mutual medicine

November 18, 2004

From developing strategy for a product at the earliest pre-launch phase to promoting older, established products the pharma industry has …

Feature

FDA requests further safety data for Arcoxia

November 10, 2004

News

PPRS deal to cut NHS drugs bill by 7%

November 9, 2004

News

Warner Chilcott agrees

November 8, 2004

News

Microsoft licensing deal to save NHS

November 8, 2004

News

PR: the power of perceptions

November 3, 2004

Pharma is taking an increasing interest in PR and what it can achieve in the marketing mix. But with a …

Feature

Lilly’s Alimta ready for UK launch

November 2, 2004

Lilly's chemotherapy drug Alimta is to be launched in the UK for the treatment of malignant pleural mesothelioma, a type …

News

Mission to maximise

November 2, 2004

We all know that 'less is more'. What clearer mission could you have as a marketer – take this product …

Feature

Black box warning for antidepressants in US

November 2, 2004

The industry's biggest selling antidepressants will all have to carry the strongest possible warnings in the US, after the FDA …

News

Industry ready to reply after critics savage practices

November 2, 2004

UK regulator the MHRA and the pharmaceutical industry have been condemned for being engaged in a closed and uncritical relationship, …

News

Lonngren lashes out at late warning

November 1, 2004
EMA, EMEA, Lonngren, Vioxx

 Thomas Lonngren, the head of Europe’s medicines regulator the EMEA has spoken out about Merck’s withdrawal of Vioxx, saying the …

News

Nanotechnology: small could be big

October 27, 2004

Nanotechnology is starting to fuel the imagination and commercial aspirations of pharma companies, but sound strategies for intellectual property protection …

Feature

Pfizer warns of slowdown in 2005

October 27, 2004

Pfizer has warned that growth in 2005 could be held back by generic competition and other increasing market pressures.The company's …

News

Prexige launch delayed

October 27, 2004

Novartis has delayed the launch of its potential blockbuster painkiller Prexige until 2007, in the wake of Vioxx's withdrawal. The …

News

Landmark pharmacy contract agreed in England and Wales

October 27, 2004

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025